BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36914036)

  • 1. Ethyl palmitate, an anti-chikungunya virus principle from Sauropus androgynus, a medicinal plant used to alleviate fever in ethnomedicine.
    Sagna A; Nair RVR; Hulyalkar N; Rajasekharan S; Nair VTG; Sivakumar KC; Suja SR; Baby S; Sreekumar E
    J Ethnopharmacol; 2023 Jun; 309():116366. PubMed ID: 36914036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sauropus androgynus L. Merr. on dengue virus-2: An in vitro and in silico study.
    Joshi RK; Agarwal S; Patil P; Alagarasu K; Panda K; Prashar C; Kakade M; Davuluri KS; Cherian S; Parashar D; Pandey KC; Roy S
    J Ethnopharmacol; 2023 Mar; 304():116044. PubMed ID: 36528212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plants extracts from Cameroon pharmacopeia strongly inhibit the Chikungunya virus infection by targeting entry and replication steps.
    Simo Nemg FB; De S; Keshry SS; Mamidi P; Njayou FN; Demanou M; Moundipa Fewou P; Chattopadhyay S
    J Ethnopharmacol; 2022 Oct; 296():115458. PubMed ID: 35728708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
    Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vathasura Kudineer, an Andrographis based polyherbal formulation exhibits immunomodulation and inhibits chikungunya virus (CHIKV) under invitro conditions.
    Hasan A; Devi Ms S; Sharma G; Narayanan V; Sathiyarajeswaran P; Vinayak S; Sunil S
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115762. PubMed ID: 36181982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus.
    Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD
    Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro Studies on The Inhibition of Replication of Zika and Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus cervicornis.
    Cirne-Santos CC; de Souza Barros C; de Oliveira MC; Rabelo VW; Azevedo RC; Teixeira VL; Ferreira DF; de Palmer Paixão ICN
    Sci Rep; 2020 May; 10(1):8263. PubMed ID: 32427940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
    Dutta SK; Sengupta S; Tripathi A
    In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
    PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication.
    Di Mola A; Peduto A; La Gatta A; Delang L; Pastorino B; Neyts J; Leyssen P; de Rosa M; Filosa R
    Bioorg Med Chem; 2014 Nov; 22(21):6014-25. PubMed ID: 25282648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4'-Fluorouridine inhibits alphavirus replication and infection
    Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
    mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
    Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
    Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of stearylamine against chikungunya virus.
    Jeengar MK; Kurakula M; Patil P; More A; Sistla R; Parashar D
    Chem Phys Lipids; 2021 Mar; 235():105049. PubMed ID: 33422549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of medicinal herbs for Anti-CHIKV activity.
    Raghavendhar S; Tripati PK; Ray P; Patel AK
    Virology; 2019 Jul; 533():45-49. PubMed ID: 31082733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazonaphthyridine effects on Chikungunya virus replication: Antiviral activity by dependent and independent of interferon type 1 pathways.
    Ruiz UEA; Santos IA; Grosche VR; Fernandes RS; de Godoy AS; Torres JDA; Freire MCLC; Mesquita NCMR; Guevara-Vega M; Nicolau-Junior N; Sabino-Silva R; Mineo TWP; Oliva G; Jardim ACG
    Virus Res; 2023 Jan; 324():199029. PubMed ID: 36565816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
    Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
    J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Alagarasu K; Patil P; Kaushik M; Chowdhury D; Joshi RK; Hegde HV; Kakade MB; Hoti SL; Cherian S; Parashar D
    Front Cell Infect Microbiol; 2022; 12():866452. PubMed ID: 35463636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.